Blog
About

7
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: not found
      • Article: not found

      Hepatitis E and pregnancy: current state

      , ,

      Reviews in Medical Virology

      Wiley-Blackwell

      Read this article at

      ScienceOpenPublisher
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Related collections

          Most cited references 51

          • Record: found
          • Abstract: found
          • Article: found
          Is Open Access

          EDITORIAL

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            Editorial

              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Hepatitis E and pregnancy: understanding the pathogenesis.

              Hepatitis E virus (HEV) is a single-stranded RNA virus that causes large-scale epidemics of acute viral hepatitis, particularly in developing countries. In men and non-pregnant women, the disease is usually self-limited and has a case-fatality rate of less than <0.1%. However, in pregnant women, particularly from certain geographical areas in India, HEV infection is more severe, often leading to fulminant hepatic failure and death in a significant proportion of patients. In contrast, reports from Egypt, Europe and the USA have shown that the course and severity of viral hepatitis during pregnancy is not different from that in non-pregnant women. The reasons for this geographical difference are not clear. The high mortality rate in pregnancy has been thought to be secondary to the associated hormonal (oestrogen and progesterone) changes during pregnancy and consequent immunological changes. These immunological changes include downregulation of the p65 component of nuclear factor (NF-kappaB) with a predominant T-helper type 2 (Th2) bias in the T-cell response along with host susceptibility factors, mediated by human leucocyte antigen expression. Thus far, researchers were unable to explain the high HEV morbidity in pregnancy, why it is different from other hepatitis viruses such as hepatitis A with similar epidemiological features and the reason behind the difference in HEV morbidity in pregnant women in different geographical regions. The recent developments in understanding the immune response to HEV have encouraged us to review the possible mechanisms for these differences. Further research in the immunology of HEV and pregnancy is required to conquer this disease in the near future.
                Bookmark

                Author and article information

                Journal
                Reviews in Medical Virology
                Rev. Med. Virol.
                Wiley-Blackwell
                10529276
                May 2017
                May 20 2017
                : 27
                : 3
                : e1929
                Article
                10.1002/rmv.1929
                © 2017

                Comments

                Comment on this article